Drug: doxorubicin hydrochloride Quarter: 2016Q3
Total Records: 406 Number of Pages: 21
| DRUGNAME | PT | EventCount |
|---|---|---|
| DOXORUBICIN HYDROCHLORIDE. | Depression | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Dermatitis acneiform | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Device related infection | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Diabetes insipidus | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Diffuse large B-cell lymphoma | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Disease recurrence | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Dizziness | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Drug hypersensitivity | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Drug-induced liver injury | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Dry skin | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Endocrine toxicity | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Enterococcus test positive | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Erythema | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Escherichia sepsis | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Ewing's sarcoma | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Extranodal marginal zone B-cell lymphoma (MALT type) | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Facial nerve disorder | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Fistula | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Follicle centre lymphoma, follicular grade I, II, III recurrent | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Fracture | 1 |
Total Records: 406 Number of Pages: 21